Axsome Therapeutics, Inc. (AXSM)
245.64
+10.50
(+4.47%)
USD |
NASDAQ |
Jun 09, 16:00
245.91
+0.27
(+0.11%)
After-Hours: 20:00
Axsome Therapeutics EPS Diluted (Quarterly) : -1.261 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 0.6899 |
| Filana Therapeutics, Inc. | -0.2139 |
| CorMedix, Inc. | 0.4151 |
| Eloxx Pharmaceuticals, Inc. | -0.8566 |
| Cannabis Global, Inc. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.54M |
| Revenue (Quarterly) | 191.20M |
| Total Expenses (Quarterly) | 255.74M |
| Enterprise Value | 12.55B |
| Gross Profit Margin (Quarterly) | 91.06% |
| Profit Margin (Quarterly) | -33.76% |
| Earnings Yield | -1.52% |
| Normalized Earnings Yield | -1.482 |